Justice Prevails! I am pleased to announce that we have successfully defended ourselves against the frivolous lawsuit brought against the company and myself by one of our shareholders. It’s been a long and extremely stressful 3 years, and I am pleased with the Court’s decision yesterday. Rest assured, we will regroup, and I will try my best to re-engage conversations with Intel’s microchip division and the pharmaceutical company we were negotiating with when the lawsuit was filed. Our algorithms, which potentially can benefit anyone who spends hours with their cellphones or computers, are simply too valuable not to be made available to the public. For those of you who had reached out to me personally to show your unwavering support over the past 3 years, I want to thank each one of you from the bottom of my heart! Thank you.

Dear Shareholders,
Our mission to minimize Digital Eye Strain and Childhood Myopia is under attack! One of our current shareholders has filed a frivolous lawsuit against the company and myself in an effort to get her capital investment back, falsely accusing myself and the company for mismanagement. Although we have all the evidence to prove her wrong in court, plus I had never drawn any salaries for myself since the company inception, the legal cost to defend this frivolous lawsuit proved too high for me and my practice to continue self-funding for the software development. As a result, I have no choice but to halt all software developments until this lawsuit comes to a resolution. This frivolous lawsuit has created huge obstacles for me to go out and raise additional capital as well. But rest assured, our goal to combat Childhood Myopia and Digital Eye Strain will not be altered because of it. I will keep everyone informed when I have more news to update regarding this. Thank you.

Dear Shareholders, It is sadly confirmed that Intel would not deploy the new project with our functionality at this time due to cost cutting. We have, however, pivoted our efforts to app development for mobile device users. Although it would not be as easy to implement as an innate software that comes with new devices, I believe it’s the next best solution to introduce our features to the mass. We have also contracted Donny Suh, M.D. recently to be a part of our advisor team. Dr. Suh works at Gavin Herbert Eye Institute at University of California at Irvine as a Professor and Chief of Pediatric Ophthalmology and Strabismus, and is currently the Chairperson of Ophthalmology Section of American Academy of Pediatrics.

Dear Shareholders, As some of you might have known, we had been working with a leading semiconductor chip manufacturer to license our algorithm as part of their global school district initiative. As of now, It looks like we have not won the licensing contract with them, as they have been completely silent this year. And because of this puzzling development, we had to part ways with our CEO, MR. Lars Nordenlund, and hit the restart button for the project. Rest assured, we will continue to work hard to find willing partners to bring our idea to market in a large scale, so every computer/cellphone/tablet users in the world could benefit from our algorithm designed to minimize Digital Eye Strain, Screen-Induced Dry Eyes and Childhood Myopia.

Respectfully

Dr. Roger Wu

This is just a quick announcement: We are currently working with a lawyer and CPA to devise the best restructuring, fundraising and capitalization strategies, and should be able to provide exact numbers within 2-3 weeks. The restructured firm will be registered in Delaware (Instead of California that’s currently registered). Thank you.

It is my honor and pleasure to announce that we have successfully recruited Lars Nordenlund to be our new CEO to lead us in our battle against Digital Eye Strain and Childhood Myopia. Lars was the former Senior Director of Global ISV Partnership department at Microsoft, and CEO/Founder at Arcules, a division of Canon, Inc.. ​He is a global visionary thought leader with a successful track record of conceiving and delivering breakthrough growth strategies, corporate reinvention and business transformations. He has in the last twenty years been a leading authority on strategic change, disruptive innovation, digital transformation and design thinking, with special emphasis on the wonder and power to disrupt with technology, AI, IoT, enterprise software, cloud video, SaaS and media advertising. Welcome aboard!

I just wanted to provide everyone with a quick update: We have recently finished shooting several educational videos about Childhood Myopia, Digital Eye Strain, etc., and sent them to a major microchip manufacturer for review. These videos will be used for their school district initiatives if approved. Thanks.

Dear Eyes 4 Lives’ Shareholders, I have some exciting news to share with you: First: we have successfully modified our software so it’s now able to run on Altek’s next-gen microchip. It’s been tested on the chip’s simulator currently. Second: we have signed a second NDA with a pharmaceutical company’s corporate VC division and entered due diligence process with them since 03/21/22. Thank you.

Dear E4L Shareholders, I like to wish everyone a happy and healthy holiday season! We have made an internal decision at E4L this month. Starting December of 2021, Intel is being moved down from our priority strategic partner list. As a small startup, we simply can’t afford to sit around and wait for them to decide on their next move. Our new priority is now working with Altek Corporation’s latest M1 microchip. Altek had just provided us with details of the chip design and we plan on modifying our software to accommodate it. Estimated time required is 3 months for the first demo. Thank you.

Dear Eyes 4 Lives, Inc’s shareholders: We have just recently concluded our first raise at Netcapital and received the funds. I want to thank everyone for your trust and sharing our vision to build a healthier device usage habit for current and future generations. Your shares can be viewed on your Netcapital dashboard. Thank you for your patience. Regards Dr. Roger Wu

We have officially signed an agreement with Independent Investment Bankers Corp. (IBB) and Park Road Advisors to lead our capital raising process today.

Hi Everyone, my name is Dr. Roger Wu and I am the Founder of Eyes 4 Lives, Inc.. To begin, I like to thank everyone who had already made the commitment to invest in this unique yet meaningful project. As a clinician, I am seeing more patients with eye problems caused by our reliance on smart phones, tablets, and computers. That’s why this company was created, and we currently offer the only full-featured solution to this growing problem called Digital Eye Strain. Our goal to commercialize later this year will be one step closer with this investment, and thank you for joining our mission to make a lasting impact!

We have just been invited by one of the biggest vision insurance companies in the U.S., VSP, to present our unique project at their Digital Eye Strain Innovation Showcase on 03/01/2021.